Absci Investor Presentation Deck
December 2023, 42 slides
  1. Absci
  2. Related Decks
  3. Investor Presentation Decks
| Absci
| Absci
what if the next transformative drug was not discovered but created at a click of a button | Absci
the drug discovery paradigm is ripe for disruption a | Absci
unlocking the potential of generative in biology requires scalable biological data | Absci
scalable biological data enables true generative for drug discovery a a a a a | Absci
instead of finding the needle in the haystack is creating the needle | Absci
at the future is now with our integrated drug creation platform | Absci
integrated drug creation platform | Absci
integrated drug creation platform | Absci
integrated drug creation platform | Absci
cycles completed within weeks train | Absci
is the first to design and validate novel antibodies using zero shot generative | Absci
the leading full stack platform for drug creation | Absci
antibody development using generative | Absci
drug creation with zero shot generative | Absci
design of her antibodies | Absci
data highlights | Absci
data highlights | Absci
scaling our development with high throughput validation | Absci
leveraging wet lab and for parametric lead optimization | Absci
from designs to optimized therapeutics | Absci
valent lead optimization towards a broad spectrum antibody | Absci
generate information rich libraries for model training | Absci
ace assay platform generates large high quality training sets enabling in silico affinity predictions | Absci
model searches mutational space and top predictions are validated | Absci
optimized binding to multiple variants | Absci
optimization for dual or valent increases potential optimization i | Absci
of top natural variants exhibit higher binding affinity than wild type | Absci
optimization for dual or valent increases potential optimization | Absci
reverse immunology platform unifies target and antibody discovery in a single enabling potential first in class | Absci
reverse immunology simultaneous target and antibody discovery gees | Absci
tertiary lymphoid structures the cornerstone of reverse immunology approach | Absci
ways to work together on target discovery | Absci
potential to enable our partners with | Absci
technology validated through industry leading collaborations | Absci
accelerating time to clinic while increasing probability of success better for patients faster | Absci
ultra efficient generation | Absci
internal program partnerships have attractive risk return profiles | Absci
team of innovators and to achieve the impossible hire | Absci
the drug creation revolution is only just beginning | Absci
this revolution is only just beginning | Absci
See More
Absci
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Drug discovery
Recent decks by Absci
Investor Conference
January 2024
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
July 2023
See all presentations by Absci (12 decks)
Related decks
BenevolentAI
Investor Presentation
September 2024
Relay Therapeutics
IPO
July 2020
Evotec
Investor Presentation
July 2022
23andMe
Investor Day
January 2022
Exscientia
Investor Day
January 2024
BenevolentAI
Investor Presentation
October 2022
AbCellera
Investor Presentation
May 2023
ATAI
Investor Presentation
June 2020
Recent decks by Absci
See all presentations (12 decks)
Investor Conference
January 2024
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
July 2023
BenevolentAI
Investor Presentation
September 2024
Relay Therapeutics
IPO
July 2020
Evotec
Investor Presentation
July 2022
23andMe
Investor Day
January 2022
Exscientia
Investor Day
January 2024
BenevolentAI
Investor Presentation
October 2022
AbCellera
Investor Presentation
May 2023
ATAI
Investor Presentation
June 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights